Literature DB >> 28113140

Simultaneous determination of multiple bioactive components of Bu-zhong-yi-qi-tang in rat tissues by LC-MS/MS: Application to a tissue distribution study.

Min He1, Wenwen Chen1, Mengmeng Wang2, Yu Wu1, Jin Zeng1, Zhirong Zhang1, Shujiao Shen1, Jian Jiang3.   

Abstract

A liquid chromatography coupled with electrospray ionization mass spectrometry method was developed and validated for simultaneous determination of seven bioactive constituents including astragaloside IV, calycosin, glycyrrhizic acid, enoxolone, saikosaponin D, ferulic acid and hesperiden in rats' various tissues using diclofenac as the internal standard (IS). Biological samples were pretreated by protein precipitation with acetonitrile. The chromatographic separation was carried out on a C18 column with a gradient mobile phase consisting of acetonitrile and water (containing 0.1% formic acid and 4mM ammonium acetate). All analytes and IS were quantitated through electrospray ionization in negative ion multiple reaction monitoring mode. The mass transitions were as follows: m/z 829.7→783.3 for astragaloside IV, m/z 283.3→267.7 for calycosin, m/z 821.6→350.0 for glycyrrhizic acid, m/z 469.9→425.2 for enoxolone, m/z 825.7→779.6 for saikosaponin D, m/z 192.5→133.9 for ferulic acid, m/z 609.1→301.0 for hesperiden and m/z 293.6→249.9 for the IS, respectively. The lower limits of quantification for the seven analytes in different rat tissues were 0.2-20ng/mL. Bu-zhong-yi-qi-tang (Hochuekkito in Japan, Bojungikki-tang in Korea) is one of the most frequently prescribed traditional herbal formulas used in Korea, Japan, and China to treat gastrointestinal diseases, cancer and chronic fatigue syndrome. The validated method was successfully applied to a tissue distribution study of the seven components in rat tissue after oral administration of Bu-zhong-yi-qi-tang concentrated granule. The results of the tissue distribution study showed that the high concentration of seven components were mainly in the gastrointestinal tract.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bu-zhong-yi-qi-tang; LC–MS/MS; Tissue distribution

Mesh:

Substances:

Year:  2017        PMID: 28113140     DOI: 10.1016/j.jchromb.2017.01.023

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Seihai-to (TJ-90)-Induced Activation of Airway Ciliary Beatings of Mice: Ca2+ Modulation of cAMP-Stimulated Ciliary Beatings via PDE1.

Authors:  Haruka Kogiso; Yukiko Ikeuchi; Masako Sumiya; Shigekuni Hosogi; Saori Tanaka; Chikao Shimamoto; Toshio Inui; Yoshinori Marunaka; Takashi Nakahari
Journal:  Int J Mol Sci       Date:  2018-02-26       Impact factor: 5.923

2.  Buzhongyiqi Decoction Protects Against Loperamide-Induced Constipation by Regulating the Arachidonic Acid Pathway in Rats.

Authors:  Wan-Jun Ju; Ze-Kuo Zhao; Shao-Li Chen; Dan-Dan Zhou; Wen-Ning Yang; Xiao-Ping Wen; Guang-Li Du
Journal:  Front Pharmacol       Date:  2020-04-03       Impact factor: 5.810

Review 3.  Herbal Formula Modified Buzhong-Yiqi-Tang for Functional Constipation in Adults: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Hanlin Gong; Feng Qin; Hongbo He
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-16       Impact factor: 2.629

4.  Differential Regulation of NF-κB and Nrf2 by Bojungikki-Tang Is Associated with Suppressing Lung Inflammation.

Authors:  Soo Ryun Park; Kyun Ha Kim; Min Jung Kwun; Ji Yeon Lee; Ran Won; Chang Woo Han; Jun Yong Choi; Myungsoo Joo
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-30       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.